17 Oct 2017 | 10:23 PM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
496.95
-3.60
(-0.71 %)
17 Oct 2017 | 03:47 PM
Change company
  • Open (Rs)
    499.00
  • Prev. close (Rs.)
    500.55
  • High (Rs.)
    502.00
  • Low (Rs.)
    494.75
  • 52W H (Rs.)
    558.00
  • 52W L (Rs.)
    329.95
  • Volume
    329424
  • MCap (Rs in Cr.)
    50,874.91
499.75
-3.25
(-0.65 %)
  • Open (Rs)
    502.80
  • High (Rs)
    503.15
  • Low (Rs)
    496.10
  • Prev. close(Rs)
    503.00
  • Contracts Tra.
    14,54,400
  • Turnover (Cr.)
    73
  • Open Interest
    32,56,000
  • Open Int. chg
    32,52,800.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
14.53
Operating Margin (%)
20.18
Gross Profit Margin (%)
16.21
Net Profit Margin (%)
15.77
Total Debt/Equity
0.71
Dividend payout Ratio (Net Profit)
26.50
Earning Retention Ratio
73.42

News

12 Oct 2017 - 14:31:00-Drug firm Zydus Cadila on Thursday said it has received the final approval from the US health regula...
09 Oct 2017 - 09:23:00-Leading pharma major Zydus Cadila has said that it has received the final approval from the USFDA to...
05 Oct 2017 - 12:28:00-Zydus Cadila said that it has received the final approval from the US Food and Drug Administration (...
04 Oct 2017 - 14:35:00-Cadila Healthcare said that it has received USFDA approval to market Desmopressin Nasal Spray Soluti...

Announcements

14-Oct-2017
Cadila Healthcar - Press Release
14-Oct-2017
Cadila Healthcar - Press Release / Media Release
12-Oct-2017
Cadila Healthcar - Press Release
12-Oct-2017
Cadila Healthcar - Press Release / Media Release
11-Oct-2017
Cadila Healthcar - Board Meeting On November 14 2017

Religare Research

17 Oct 2017 | 11:24 AM
The Indian rupee was on a roar till mid of September and tested 63.57 levels gaining over six per ce...
17 Oct 2017 | 10:22 AM
The Indian rupee rose to an over three-week high against the dollar, as the nation's trade gap shran...
17 Oct 2017 | 09:33 AM
Highlights: • As Diwali festival approaches, trading activities start falling in mandis. With ...
17 Oct 2017 | 09:30 AM
Gold fell from three week high, weighed by strong US dollar. Today MCX to unveil first commodity opt...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,405 189.90 87.81 0.36
10,00,405 189.90 32.37 0.36
10,00,405 189.90 87.81 0.36
10,00,405 189.90 21.95 0.70
10,00,405 189.90 91.07 0.37

Shareholding Pattern

       
Promotors74.79%
Mutual Funds/UTI3.83%
FI/Banks3.60%
Insurance3.60%
FII9.77%
Government0.08%
Others2.95%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,757.00(0.39)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,443.45(-0.05)
3317
 Dr. Reddy`s Laboratories Ltd.
2,382.35(-0.62)
3294
 Alkem Laboratories Ltd.
1,824.00(-0.87)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Cadila Healthcare Ltd.10.40-28.0045.05
NIFTY(S&P CNX)81.35407.301,095.15
BSE SENSEX185.40534.383,195.50
BSE 50079.55665.231,541.02

Corporate Details

Key Personal
Apurva S Diwanji
Addnl.Independent Director
Ganesh N Nayak
Whole Time Director & COO
Pankaj R Patel
Chairman
Key Address
Registered Office
Zydus Tower Satellite Cross Roads Sarkhej-Gandhinagar Highway,Ahmedabad,Gujarat

Tel:079-26868100 26868101 26868102 26868103-20, Fax:079-26862365 26862366

investor.grievance@zyduscadila.com
http://www.zyduscadila.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)